UNSPSC 51101650: Dehydroemetine

This classification denotes an antiprotozoal agent with the molecular formula C29H38N2O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7S79QT1T91, chemically known as 2,3-didehydroemetine dihydrochloride (.+-.)- but generally known as dehydroemetine, which bears US NIH Compound Identifier 17558. European Medicines Agency schedules Dehydroemetine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06946MIG. The term DEHYDROEMETINE is an International Non-Proprietary Name.

UNSPSC 51101650 Dehydroemetine, a Commodity code, nominally designates a specific pharmaceutical active ingredient, but recent state and local solicitations tagged under this code do not procure dehydroemetine itself; instead, they solicit finished pharmaceutical products, medical supplies, and pharmacy benefit program services. State and local governments are using the code to procure naloxone and drug deactivation systems, medical and first aid supplies for emergency response, generic multi-source pharmaceuticals and over-the-counter products through cooperative purchasing arrangements, and direct-to-manufacturer prescription fulfillment services. The issuing bodies include county health departments, municipal fire departments, state health and human services commissions, and multi-state cooperative purchasing alliances. No dedicated repeat buyers emerge from the recent record, and no set-aside or preference programs are explicitly designated in these opportunities.

Recent activity spans Florida, Texas, Minnesota, and Oregon. Representative opportunities include Seminole County, Florida's IFB 60459723LAS (posted June 30, 2026, due July 26, 2023) seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually for quarterly delivery to the county community health building; the City of Tampa's IFB 26-P-00145 (posted March 25, 2026, due March 13, 2026) for 169 line items of medical and first aid supplies for the Tampa Fire Department Rescue Division with an estimated contract value of $700,000 and a sheltered-market set-aside for certified Small Local Business Enterprises; the Minnesota Multistate Cooperative Purchasing Alliance's RFP S1070000015802 (posted January 20, 2026, due March 26, 2026) to establish multiple contracts for generic multi-source pharmaceuticals and OTC products across participating state and local facilities; and the Texas Health and Human Services Commission's RFI HHS0017013 (posted April 3, 2026, due April 3, 2026) soliciting vendor capabilities for direct-to-manufacturer prescription programs. The mismatch between the code's nominal scope and the actual procurement activity signals that this code may be misapplied in state and local systems.